Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy
PHASE3CompletedINTERVENTIONAL
Enrollment
212
Participants
Timeline
Start Date
March 31, 1999
Study Completion Date
October 31, 2009
Conditions
Multiple Myeloma
Interventions
DRUG
Melphalan
Trial Locations (1)
1160
Wilhelminenspital, 1st Medical Department-center for oncology and hematology, Vienna
All Listed Sponsors
lead
Austrian Forum Against Cancer
OTHER
NCT00205764 - Tandem High Dose Melphalan Versus Triple Intermediate Dose Melphalan and Stem Cell Transplantation in Induction Phase and Prednisolone/IFN Versus IFN in Maintenance Therapy | Biotech Hunter | Biotech Hunter